IDXX - アイデックス・ラボラトリ―ズ （IDEXX Laboratories Inc.） アイデックス・ラボラトリ―ズIDXXのチャート
IDXXの企業情報
| symbol | IDxx |
|---|---|
| 会社名 | Idexx Laboratories Inc. （アイデックス・ラボラトリ―ズ） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: In Vitro_In Vivo Diagnostic Substances |
| 業種 | 医療機器_医療用品_ディストリビュ―タ― 医療関連（Health Care） |
| 概要 | 事業概要 アイデックス・ラボラトリーズ（IDEXX Laboratories Inc.）は製品を開発・製造・販売し、獣医畜、家畜、家禽、酪農場、水試験市場向けのサービスを提供する。また、人間のポイント・オブ・ケア診断診断市場向けの携帯用電解液及び血液ガス分析器のラインを販売する。同社はコンパニオンアニマルグループ、水質製品、家畜・家禽・乳製品、その他4つの事業セグメントを運営する。コンパニオンアニマルグループ事業は、獣医学市場向けの診断及び情報技術に基づく製品とサービスが含まれる。家畜・家禽・乳製品事業は、家畜および家禽の健康診断製品およびサービスを提供する。その他事業は、医薬品ラインとアウトライセンス契約により、ヒューマン・ポイント・オブ・ケアの医療診断市場向け製品を組み合わせて提供する。その製品及びサービスには、器具、消耗品、及び迅速アッセイ検査キットを含む、ポイントオブケアの獣医診断製品が含まれる。 アイデックス・ラボラトリ―ズは、米国の動物用医療機器製造会社。動物のヘルスケア、食品衛生および水質管理における検査機器のほか、診断関連サ―ビスを提供する。事業は、コンパニオン・アニマル・グル―プ、家畜・家禽・酪農、水質検査、その他の4部門で構成される。本社はメイン州ウェストブルック。 IDEXX Laboratories, Inc. is a member of the S&P 500® Index and is a leader in pet healthcare innovation, offering diagnostic and software products and services that deliver solutions and insights to practicing veterinarians around the world. IDEXX products enhance the ability of veterinarians to provide advanced medical care, improve staff efficiency and build more economically successful practices. IDEXX is also a worldwide leader in providing diagnostic tests and information for livestock and poultry and tests for the quality and safety of water and milk and point-of-care and laboratory diagnostics for human medicine. Headquartered in Maine, IDEXX employs more than 9,000 people and offers products to customers in over 175 countries. |
| 本社所在地 | One IDEXX Drive Westbrook ME 04092 USA |
| 代表者氏名 | Jonathan W. Ayers ジョナサン・W・エアーズ |
| 代表者役職名 | Chairman of the Board President Chief Executive Officer 取締役会長兼最高経営責任者（CEO） |
| 電話番号 | +1 207-556-0300 |
| 設立年月日 | 1983年 |
| 市場名 | NASDAQ National Market System |
| ipoyear | 1991年 |
| 従業員数 | 7600人 |
| url | www.idexx.com |
| nasdaq_url | https://www.nasdaq.com/symbol/idxx |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） 540.80200 |
| 終値（lastsale） | 224.43 |
| 時価総額（marketcap） | 19433610050.52 |
| 時価総額 | 時価総額（百万ドル） 18911.47 |
| 売上高 | 売上高（百万ドル） 2116.505 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 19673.451 |
| 当期純利益 | 当期純利益（百万ドル） 337.91000 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 IDEXX Laboratories Inc. revenues increased 15% to $1.12B. Net income increased 28% to $198.1M. Revenues reflect CAG segment increase of 16% to $978.3M Other segment increase from $10.4M to $67.2M Water segment increase of 13% to $61.8M United States segment increase of 13% to $684.2M. Net income benefited from CAG segment income increase of 22% to $230.2M. |
IDXXのテクニカル分析
IDXXのニュース
IDEXX Laboratories: Excellent Business But Extremely Overpriced 2023/02/24 20:26:45 Seeking Alpha
IDEXX Laboratories delivered solid and consistent results that rival the Googles, Metas, and Microsofts out there. Click here for more on IDXX.
Is IDEXX Laboratories (IDXX) a High-Growth Stock? 2023/02/13 10:34:19 Insider Monkey
Baron Funds, an investment management company, released its “Baron Asset Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here. The fund increased by 12.21% in the fourth quarter, outperforming the Russell Midcap Growth Index which returned 6.90%. Stock selection and underexposure to stocks with high measures of Residual Volatility and […]
IDEXX Laboratories Q4 Earnings: Strong Margin Expansion But Too Expensive 2023/02/08 22:22:13 Seeking Alpha
IDEXX Laboratories'' share price has increased over 55% since last October. See why I rate IDXX stock as a hold.
Legionella Testing Market Trends, Size, Share, Growth, Industry Analysis, Advance Technology and Forecast 2027 2023/02/08 16:40:00 SBWire
In December 2021, IDEXX Laboratories, Inc. (US) acquired Reference Laboratories (Finland) to expanded the company''s international reference laboratory presence. Northbrook, IL 60062 -- ( SBWIRE ) -- 02/08/2023 -- Legionella Testing Market is projected to grow from USD 296 million in 2022 to USD 439 million by 2027, at a CAGR of 8.2% from 2022 to 2027, according to a new report by MarketsandMarkets™. ,as businesses around the world look to protect their employees, customers and other visitors. Legionella testing is becoming an increasingly important part of many businesses'' safety and health protocols. As awareness of Legionella bacteria and the threat it poses to the health of building occupants grows, so does the demand for testing to ensure that Legionella levels in water systems remain low. In this blog post, we''ll take a look at the current state of the Legionella testing market, the key drivers of its growth and the challenges it faces. We''ll also look at the different types of Legionella tests available, the benefits they offer, and the importance of conducting regular testing.
Here''s How Much $100 Invested In IDEXX Laboratories 15 Years Ago Would Be Worth Today 2023/02/07 15:01:49 Benzinga
IDEXX Laboratories (NASDAQ: IDXX ) has outperformed the market over the past 15 years by 13.26% on an annualized basis producing an average annual return of 20.86%. Currently, IDEXX Laboratories has a market capitalization of $40.54 billion. Buying $100 In IDXX: If … Full story available on Benzinga.com
Veterinary Pain Management Global Market Report 2022: Ukraine-Russia War Impact 2022/12/21 20:34:00 GlobeNewswire
Major players in the veterinary pain management market are CH Boehringer Sohn AG & Co KG, Zoetis Inc, Merck & Co Inc, Elanco Animal Health Incorporated, Ceva Santé Animale, Vetoquinol SA, Norbrook Laboratories Inc, Dechra Pharmaceuticals PLC, Chanelle Pharma, IDEXX Laboratories Inc, Assisi Animal Health, Bayer AG, Eli Lilly and Company, Novartis AG, and The International Veterinary Academy of Pain Management. Major players in the veterinary pain management market are CH Boehringer Sohn AG & Co KG, Zoetis Inc, Merck & Co Inc, Elanco Animal Health Incorporated, Ceva Santé Animale, Vetoquinol SA, Norbrook Laboratories Inc, Dechra Pharmaceuticals PLC, Chanelle Pharma, IDEXX Laboratories Inc, Assisi Animal Health, Bayer AG, Eli Lilly and Company, Novartis AG, and The International Veterinary Academy of Pain Management.
Veterinary Reference Laboratory Global Market Report 2022: Ukraine-Russia War Impact 2022/12/21 20:29:00 GlobeNewswire
Major players in the veterinary reference laboratory market are IDEXX Laboratories Inc. , VCA Animal Hospitals, GD Animal Health, Boehringer Ingelheim, Zoetis Inc. , Neogen Corporation, Laboklin GmbH & Co. Major players in the veterinary reference laboratory market are IDEXX Laboratories Inc. , VCA Animal Hospitals, GD Animal Health, Boehringer Ingelheim, Zoetis Inc. , Neogen Corporation, Laboklin GmbH & Co.
U.S. avian flu outbreak worst in history (NASDAQ:IDXX) 2022/11/25 16:00:21 Seeking Alpha
Avian flu outbreak has so far claimed the lives of 50.54M birds in the U.S. this year, making it the nation''s worst on record, according to data from the U.S. Department of Agriculture
Companies - Is There More Room For Growth In IDEXX Laboratories Stock? 2022/11/15 15:13:05 Business Mag
This 137% growth for IDXX stock since late 2018 can primarily be attributed to 1 the company''s P/S ratio rising 53% to 11.1x trailing revenues, from 7.3x in 2018, 2.
IDEXX Laboratories Recent Insider Activity 2022/11/10 16:32:53 Benzinga
Jonathan Jay Mazelsky , President & CEO at IDEXX Laboratories (NASDAQ: IDXX ), reported a large insider sell on November 9, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Mazelsky sold 13,230 shares of IDEXX Laboratories . The total transaction amounted to $5,060,319. IDEXX Laboratories shares are trading up 6.32% at $403.87 at the time of this writing on Thursday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily … Full story available on Benzinga.com
U.S. avian flu outbreak worst in history (NASDAQ:IDXX) 2022/11/25 16:00:21 Seeking Alpha
Avian flu outbreak has so far claimed the lives of 50.54M birds in the U.S. this year, making it the nation''s worst on record, according to data from the U.S. Department of Agriculture
Companies - Is There More Room For Growth In IDEXX Laboratories Stock? 2022/11/15 15:13:05 Business Mag
This 137% growth for IDXX stock since late 2018 can primarily be attributed to 1 the company''s P/S ratio rising 53% to 11.1x trailing revenues, from 7.3x in 2018, 2.
IDEXX Laboratories Recent Insider Activity 2022/11/10 16:32:53 Benzinga
Jonathan Jay Mazelsky , President & CEO at IDEXX Laboratories (NASDAQ: IDXX ), reported a large insider sell on November 9, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Wednesday showed that Mazelsky sold 13,230 shares of IDEXX Laboratories . The total transaction amounted to $5,060,319. IDEXX Laboratories shares are trading up 6.32% at $403.87 at the time of this writing on Thursday morning. Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm. Why Insider Transactions Are Important Insider transactions shouldn''t be used primarily … Full story available on Benzinga.com
The U.S. stock market closed lower, the Dow Jones fell 0.24% 2022/11/02 03:18:48 InstaForex
At closing time on the New York Stock Exchange, the Dow Jones was down 0.24%, the S&P 500 was down 0.41% and the NASDAQ Composite was down 0.89%. The leaders among Dow Jones index components in today''s trading were shares of JPMorgan Chase & Co. which gained 2.28p (1.81%) to close at 128.16. Nike Inc rose 1.09 pct (1.18%) to close at 93.77. Goldman Sachs Group Inc rose 3.94p (1.14%) to close at 348.45. The least gainers were shares of Apple Inc, which fell 2.69p (1.75%) to close the session at 150.65. Salesforce Inc shares rose 2.79p (1.72%) to close at 159.80, while Microsoft Corporation dropped 3.96p (1.71%) to close at 228.17. The top gainers among S&P 500 index components in today''s trading were ABIOMED Inc which gained 49.88% to 377.82, IDEXX Laboratories Inc which gained 9.80% to close at 394.93, and Hologic Inc which gained 9.34% to end the session at 74.13. Catalent Inc shares were the fallers, down 24.62% to close at 49.55. Shares of Zebra Technologies Corporation lost 15.86% and ended the session at 238.30.